Jaunt

"Medical executives can manage the complexities of product launches and achieve timely success by developing a clear product vision, navigating regulatory requirements, and implementing solid marketing and distribution strategies." - Steve Sapot #MedTechInnovation #ExecutiveLeadership #GoToMarketStrategy #MedicalDevice #FractionalExecutives #Jaunt

Steve Sapot shares some strategies for managing stress and achieving work-life balance as medical executives. #MedTechInnovation #ExecutiveLeadership #GoToMarketStrategy #MedicalDevice #FractionalExecutives #Jaunt

We are excited to announce that Shane Brown is joining Jaunt as our newest Executive Advisor! Shane brings a wealth of experience from companies like Abbott, St. Jude Medical, and most recently as President of GT Medical, where he spearheaded the commercialization of GammaTile Therapy for brain tumor patients.  Shane has deep experience throughout cardiovascular (electrophysiology, structural heart, endovascular, coronary, imaging) as well as digital health, AI, neurosurgery and precision oncology.  Shane is a proven servant leader with a track record of success in both the U.S. and international markets. He has a legacy of building cohesive teams and driving the commercialization of emerging therapies, leading to rapid revenue growth and significant accomplishments, including contributing to four acquisitions and two IPOs. Our Executive Advisors are extremely helpful to our client work, helping them advance more efficiently and successfully by sharing their extensive expertise. EAs love sharing their expertise, networks and learnings with clients wherever possible. We are grateful to have Shane join our mission and support the Jaunt team and our clients. He definitely understands the privlege and pressure of being the lead executive in a high growth organization.  Join us in welcoming Shane to the Jaunt family as we work together to advance technologies for health. #HealthTech #MedTech #Leadership #Innovation #ExecutiveAdvisor #Jaunt

Steve Sapot explains how a strategic approach rooted in thorough due diligence can help avoid common pitfalls when it comes to commercialization. #MedTechInnovation #ExecutiveLeadership #GoToMarketStrategy #MedicalDevices #FractionalExecutives #Jaunt

A great new blog post by our Executive Partner, Steve Sapot on how to achieve commercialization. Go check it out! #MedTechInnovation #ExecutiveLeadership #GoToMarketStrategy #MedicalDevices #FractionalExecutives #Jaunt https://lnkd.in/gMSrnEAK

We are thrilled to welcome Steve Sapot to the Jaunt team as our latest Executive Partner! With over a decade of experience in commercializing innovative medical devices and technologies for health, Steve has a proven track record of driving revenue growth and building successful go-to-market strategies for both startups and Fortune 500 companies. Steve is known for his action-oriented approach and exceptional ability to bridge the gap between strategy and execution. His expertise spans various clinical specialties, including surgery, radiology, oncology, and pathology, making him a perfect fit for our mission to revolutionize medtech. At Jaunt, we believe in bringing on "been there, done that" executives who can offer invaluable insights and strategic direction to our clients. Our executive partners are immediate go-to resources, ready to become an extension of your integrated team. Whether you need a specific project handled or prefer hiring on a fractional basis to avoid long-term commitments, Steve's leadership and collaborative approach ensure sustainable success. This is just the beginning. We are committed to expanding our reach and capabilities by continually adding more executive partners like Steve to our team. By doing so, we aim to better serve each and every client we touch, providing unparalleled expertise and strategic direction across all facets of the medtech industry. Join us in welcoming Steve Sapot and stay tuned for the incredible advancements we'll be making together in the medtech field! #MedTechInnovation #ExecutiveLeadership #GoToMarketStrategy #MedicalDevices #FractionalExecutives #Jaunt

At the recent MTEC | Medical Technology Enterprise Consortium Annual Meeting, Aaron Call joined Ernesto Chanona and Eric Mattson to give a high-level bootcamp-style presentation to startups in their early stages. Aaron covered Market Access focusing on the fact that the value proposition is a critical component to the equation and this must be discovered as well as quantified in an objective manor. https://lnkd.in/gyGkpxB8 #marketaccess #medtech #valueproposition

Whether we conduct the Market Opportunity Analysis for you, or you do it yourself...it's hands down where you should start! Trust us, your board and your future investors will thank you.

You want to know the best way to accelerate growth for your company? Stop competing… I learned a valuable lesson early in my career when we were working to sell an asset to a market leading strategic. We were deep into the process when the CEO came back to me and told me they were going to pass on the acquisition, stating, “it just doesn’t move the needle enough for us.” That was eye opening for me. Why would a market leading company not want a really cool technology that saved the physicians time and money and that would give them a competitive advantage? It was because it didn’t move the needle enough! Let’s face it, at the end of the day, the reason we are in business is to make money. All of our strategic decisions, all of our KPIs, all the efforts we make are to move the needle more quickly than our competitors. But in order to do so, you have to have the courage to stop competing and take a visionary approach instead. Visionary companies change our world. Their superior growth does not come from worrying about movement in market share, incremental innovation or how to schmooze a physician to their side. Visionary companies look for new ways to solve their customers' needs and to expand, re-write or change the market that exists today. In fact, the strategic decisions that wildly successful companies make that fall under the category of ‘new markets’ only account for 14% of their moves and 38% of their revenues, but produces a staggering 61% of their profits (HBR). Companies creating or changing markets achieve total shareholder returns that are 2.6 times higher than the global average (BCG). They have a 30 - 50% higher profit margin (Blue Ocean Strategy). They grow at an average of 25% compared to 15% for followers (HBR). They generate a 20% increase in income compared to those focusing on sustaining innovation (McKinsey). And finally - companies based on disruptive technologies or business models reached a $1 billion valuation 3 times faster than those in non-disruptive sectors (Forbes). The underlying growth principle that these stats boil down to in a single word is ‘efficiency’. Companies that focus on visionary products to shape, change or create new markets enjoy greater success because they achieve greater efficiencies. They achieve great efficiencies, because…you guessed it, they aren’t competing as much. The extra expense they spend in the strategic phases of their project pays huge dividends in the end. And the operative element of this is that the greater effort is not in looking for what your customers want, it is about uncovering what your customers need. You want to accelerate your growth and truly beat the competition? Spend more time uncovering where there is an opportunity for you to truly make the competition irrelevant. https://lnkd.in/gYsb8Enm #knowyourmarket #customerdiscovery #marketgrowth #MedTech #disruptiveinnovation

Value economics are increasingly important with the development and launch of medical technologies. Companies are most successful when they look at value economics that drive their entire value proposition strategy. Products should be reimbursed for what they are worth and the start of this entire strategy starts with understanding the value points. At Jaunt we work to uncover the value econmics utilizing advanced analytics to maximize profitability and enchance patient reach. Want to learn more? https://lnkd.in/gg4JaXah #valueeconomics #marketaccess #reimbursement #knowyourmarket #disruptiveinnovation